Valuation: Gennex Laboratories Limited

Market Cap 1.73B 17.99M 15.72M 14.51M 13.37M 25.2M 25.76M 173M 68.19M 848M 67.55M 66.07M 2.92B P/E 2024
26x
P/E 2025 15.4x
Enterprise Value 1.46B 15.13M 13.23M 12.2M 11.25M 21.2M 21.67M 146M 57.38M 714M 56.84M 55.59M 2.46B EV / Sales 2024
3.67x
EV / Sales 2025 1.79x
Free-Float
65.03%
Yield 2024 *
-
Yield 2025 -
05-30 Gennex Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
02-14 Gennex Laboratories Limited Resignation of Shilpa Bung, Non-Executive Independent Women Director, Effective February 14, 2026 CI
02-14 Gennex Laboratories Limited Appoints Khushbu Kachhawa as Additional Director (Non-Executive Independent Women Director) CI
02-14 Gennex Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
11-14 Gennex Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
14/08/25 Gennex Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
30/05/25 Gennex Laboratories Limited Announces Resignation of Dr. Sch Dharma Rao as Non-Executive Non-Independent Director, Effective May 30, 2025 CI
30/05/25 Gennex Laboratories Limited Appoints Sandeep Kumar Daga as Non-Executive Non-Independent Director CI
30/05/25 Gennex Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
14/02/25 Gennex Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
14/02/25 Gennex Laboratories Limited Announces Resignation of Mohammed Khaleequr Rahman as Non-Executive Non-Independent Director CI
14/11/24 Gennex Laboratories Limited Approves the Appointment of Akkali Santosh Kumar as Chief Financial Officer CI
01/10/24 Gennex Laboratories Limited Announces Board Changes CI
1 day+2.43%
1 week-6.65%
Current month-13.53%
1 month-11.63%
3 months-10.00%
6 months-28.53%
Current year-35.17%
1 week 8.95
Extreme 8.95
9.84
1 month 8.65
Extreme 8.65
12.5
Current year 7.05
Extreme 7.05
14.77
1 year 7.05
Extreme 7.05
17.25
3 years 6.15
Extreme 6.15
29
5 years 4.81
Extreme 4.81
29
10 years 1.32
Extreme 1.32
29
Manager TitleAgeSince
Chief Executive Officer 40 17/05/2012
Director of Finance/CFO - 11/11/2024
Compliance Officer 62 19/04/2023
Director TitleAgeSince
Chairman 40 -
Director/Board Member - 20/12/2020
Director/Board Member - 20/12/2020
Change 5-day change 1-year change 3-year change Capi.($)
+2.43%-6.65%-32.24%+40.24% 23.39M
+0.85%-0.80%+52.79%+159.97% 1,051B
+1.23%-1.53%+54.58%+59.41% 609B
+0.04%+2.58%+34.47%+84.84% 450B
+0.78%-0.71%+29.28%+23.25% 330B
+1.41%+0.58%+35.44%+40.53% 284B
-0.27%-1.87%+22.34%+19.92% 263B
-1.76%+2.37%-20.43%-38.01% 223B
-1.42%+0.80%+24.27%+57.85% 198B
-1.48%+3.43%+24.08%+70.06% 167B
Average +0.18%-0.18%+22.46%+51.81% 357.51B
Weighted average by Cap. +0.37%+0.02%+37.51%+78.76%

Financials

2024 2025
Net sales 867M 9M 7.87M 7.26M 6.69M 12.62M 12.9M 86.79M 34.14M 425M 33.82M 33.07M 1.46B 1.38B 14.32M 12.51M 11.55M 10.64M 20.06M 20.51M 138M 54.29M 675M 53.78M 52.6M 2.33B
Net income 132M 1.37M 1.2M 1.1M 1.02M 1.92M 1.96M 13.19M 5.19M 64.53M 5.14M 5.03M 222M 181M 1.88M 1.64M 1.52M 1.4M 2.64M 2.7M 18.14M 7.13M 88.76M 7.07M 6.91M 306M
Net Debt -413M -4.29M -3.75M -3.46M -3.19M -6.01M -6.14M -41.33M -16.26M -202M -16.1M -15.75M -696M -275M -2.85M -2.49M -2.3M -2.12M -4M -4.09M -27.5M -10.82M -135M -10.72M -10.48M -463M
Logo Gennex Laboratories Limited
Gennex Laboratories Limited is an India-based active pharmaceutical ingredient manufacturing company. The Company is engaged in the business of manufacturing of bulk drugs and intermediaries. It offers products in various therapeutic categories, including expectorant (mucolyte), relaxant (skeletal muscle relaxant), antihistamines, urinary tract analgesic, antifungals called triazoles, tricyclic antidepressant, acting muscle relaxants, muscle relaxant, selective serotonin reuptake inhibitors (SSRIS), and xanthine oxidase inhibitors. Its products include Guaifenesin, Methocarbamol, Fexofenadine Hcl, Phenazopyridine Hcl, Fluconazole, Melitracen Hcl, Mephenesin, Chlorphenesin, Sertraline Hcl and Allopurinol. The Company has manufacturing facilities in India which cater to both domestic and international markets. Its international markets include Bangladesh, Bolivia, China, Colombia, Costa Rica, Cuba, Germany, Indonesia, Iran, Iraq, Israel, Jordan, Kenya, South Korea, Malaysia and Mexico.
Employees
115
Date Price Change Volume
17/07/26 ₹9.270 +2.43% 416,150
16/07/26 ₹9.050 -2.48% 384,463
15/07/26 ₹9.280 -2.62% 358,404
14/07/26 ₹9.530 -2.26% 228,345
13/07/26 ₹9.750 -1.81% 833,904
  1. Stock Market
  2. Stocks
  3. GENNEX6 Stock